5//SEC Filing
Davidai Eli 5
Accession 0001179110-18-012367
CIK 0000826326other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 3:11 PM ET
Size
19.3 KB
Accession
0001179110-18-012367
Insider Transaction Report
Form 5
Davidai Eli
Director
Transactions
- Other
Restricted Common Stock
2018-02-28$2.00/sh+125,000$250,000→ 125,000 total(indirect: By Zori Investment Limited) - Other
Restricted Common Stock
2015-04-02$5.00/sh+50,000$250,000→ 50,000 total(indirect: By Zori Investment Limited) - Award
Stock Option (right to buy)
2018-05-14−65,000→ 154,910 totalExercise: $2.35Exp: 2025-05-14→ Common Stock (260,000 underlying) - Award
Stock Option (right to buy)
2016-01-15−104,500→ 89,910 totalExercise: $1.51Exp: 2023-01-15→ Common Stock (104,500 underlying) - Award
Stock Options (right to buy)
2016-08-26−27,210→ 27,210 totalExercise: $2.50Exp: 2023-08-26→ Common Stock (27,210 underlying) - Award
Stock Options (right to buy)
2017-02-10−74,575→ 0 totalExercise: $4.40Exp: 2027-02-10→ Common Stock (74,575 underlying)
Footnotes (10)
- [F1]This Form 5 is filed in respect of the late filing of From 3 following the appointment on June 5, 2018 of the reporting person to serve as a director of the issuer. The reporting person late-filed the Form 3 disclosures on Form 4 on June 15, 2018. The reporting person has remedidated the Form 3 filing as of even date herewith, setting forth all disclosures required as of June 5, 2018.
- [F10]On February 10, 2017, Mr Davidai was granted 74,575 shares of stock options that will vest on December 31, 2018. The stock options will expire on February 10, 2027.
- [F2]The shares were purchased by Zori Investment Limited ("Zori"), a company controlled by the reporting person, pursuant to the terms and conditions of the Rights Offering Backstop Agreement (the "Backstop Agreement"), in the form of Exhibit 10.1 filed on January 11, 2018 with the U.S. Securities & Exchange Commission under Form S-1/A of the Issuer, Registration Statement 333-221967. The Backstop Agreement was executed by the reporting person on behalf of Zori on February 6, 2018. The issuer determined on February 24, 2018 to call for the purchase by Zori of 125,000 shares of Common Stock (the "Backstop Shares") at the purchase price of $2.00 per share, in accordance with the terms and conditions of the Backstop Agreement. All such Backstop Shares were duly purchased and issued by the Company to Zori on February 28, 2018.
- [F3]Twenty-five percent (25%) of such stock options vested in full on the date of grant, May 14, 2018, and the balance of such options shall vest on each anniversary of the date of grant until all such stock options have vested in full. All such stock options shall expire on May 14, 2025, the seventh anniversary of the date of grant. As of the date of this report, 65,000 such stock options exercisable for the purchase of shares of the issuer's common stock were fully vested.
- [F4]On May 14, 2018, Mr Davidai was granted 260,000 shares of stock options where twenty-five percent (25%) of the Stock Options granted shall vest upon the date of grant and each anniversary of the date of grant until the Stock Options have vested in full. The Options shall expire on May 14, 2025, the seventh anniversary of the date of grant. As of May 14, 2018, the date of grant, 65,000 options for shares of common stock were fully vested and exercisable.
- [F5]The Reporting Person is voluntarily early reporting beneficial ownership of the 260,000 Stock Options and only 25% or 65,000 stock options are vested on the date of grant and 75% will vest equally over the next three years on the anniversary date of the grant until the Stock Options have vested in full.
- [F6]Twenty percent (20%) of such stock options vested upon the date of grant and the balance of such options shall vest on each anniversary of the date of grant until the Options have vested in full. The options shall expire on January 15, 2023, the fifth anniversary of the date of grant. As of the date of this report, 62,700 such stock options exercisable for the purchase of shares of the issuer's common stock were fully vested.
- [F7]The Reporting Person is voluntarily early reporting beneficial ownership of the 104,500 Stock Options and 60% or 62,700 of stock options have vested since the date of grant and 40% or 41,800 remain unvested. The stock options expire on January 15, 2023.
- [F8]The entirety of the 27,210 of stock options granted on August 26, 2016 vested in full on the date of grant. All such stock options will expire on August 26, 2023
- [F9]The 27,210 Stock Options vested on the date of grant.
Documents
Issuer
ARC Group Worldwide, Inc.
CIK 0000826326
Entity typeother
Related Parties
1- filerCIK 0001743194
Filing Metadata
- Form type
- 5
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 3:11 PM ET
- Size
- 19.3 KB